December 20, 2014 2:05 PM ET

Biotechnology

Company Overview of Collgard Biopharmaceuticals Ltd.

Executive Profile

Adrian Lewellyn Harris M.B, Ch.B, M.R.C.P, D.Phil

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
63--

Background

Prof. Adrian Lewellyn Harris, M.B., Ch.B., M.R.C. P., D.Phil serves as a Scientific Advisor at Collgard Biopharmaceuticals Ltd. Prof. Harris serves as an Advisor of Angstrom Pharmaceuticals, Inc. Prof. Harris is the Principal Investigator for Collgard's Phase IIa bladder cancer trial. He is a Professor of Clinical Oncology, Oxford University and has been a Director of Cancer research UK Molecular Oncology Laboratories at Churchill Hospital in Oxford, U.K., since 1988, ...

Corporate Headquarters

15 Gonen Street
Petach Tikva, -- 49170

Israel

Phone: 972 3 924 7447
Fax: 972 3 924 7446

Board Members Memberships

1996-Present
Member of Scientific Advisory Board, Non-executive Director and Member of Remuneration Committee

Education

PhD
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Collgard Biopharmaceuticals Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.